Document Detail


Homocysteine levels are not associated with cardiovascular autonomic function in elderly Caucasian subjects without or with type 2 diabetes mellitus: the Hoorn Study.
MedLine Citation:
PMID:  16313477     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: Homocysteine and cardiovascular autonomic function are both predictors of cardiovascular disease and death, particularly in patients with diabetes. The mechanism by which homocysteine causes disease is unknown. The objective of our study was to determine whether hyperhomocysteinaemia is associated with impaired cardiovascular autonomic function in an age-, sex-, and glucose tolerance-stratified sample of an elderly Caucasian population. METHODS: We studied 609 subjects, 252 with normal glucose metabolism, 173 with impaired glucose metabolism, and 184 with type 2 diabetes. Cardiac cycle duration (RR interval) and continuous finger arterial pressure were measured under three conditions: during (i) spontaneous breathing, (ii) six deep breaths over 1 min, and (iii) an active change in position from lying to standing. From these readings, 10 parameters of autonomic function were assessed (three Ewing tests, six heart rate variability tests and one test of baroreflex sensitivity). These 10 measurements were summarized in a single cardiovascular autonomic dysfunction score (CADS). RESULTS: Comparing values of autonomic function measures in the lowest versus the highest quartile of homocysteine revealed no significant association between homocysteine level and autonomic function in the whole study group, nor in the individual glucose tolerance groups. Multiple adjustment for age, sex, waist-to-hip ratio, serum creatinine, use of antihypertensives and fasting insulin, confirmed this result. We found no evidence of effect modification of glucose tolerance status on the association between homocysteine and autonomic dysfunction (P for interaction for CADS = 0.79). CONCLUSIONS: There is no evidence for an association between homocysteine levels and cardiovascular autonomic function in either diabetic or nondiabetic subjects. Cardiovascular autonomic dysfunction does not help explain why hyperhomocysteinaemia is related to cardiovascular mortality.
Authors:
A M E Spoelstra-De Man; Y M Smulders; J M Dekker; R J Heine; L M Bouter; G Nijpels; C D A Stehouwer
Related Documents :
10095817 - Decreased heart rate variability in patients with type 1 diabetes mellitus is related t...
3673667 - Autonomic neuropathy in type i diabetes: influence of duration and other diabetic compl...
1247287 - Diabetic neuropathy, a review of clinical manifestations.
17532337 - The effects of enhanced external counterpulsation on time- and frequency-domain measure...
12534317 - Recent advances in the development of an inhaled insulin product.
14715237 - Determination of the kinetics of guanine nucleotide exchange on ef-tu and ef-ts: contin...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of internal medicine     Volume:  258     ISSN:  0954-6820     ISO Abbreviation:  J. Intern. Med.     Publication Date:  2005 Dec 
Date Detail:
Created Date:  2005-11-29     Completed Date:  2005-12-27     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8904841     Medline TA:  J Intern Med     Country:  England    
Other Details:
Languages:  eng     Pagination:  536-43     Citation Subset:  IM    
Affiliation:
Institute for Cardiovascular Research, VU University Medical Center, Amsterdam, The Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Age Factors
Aged
Antihypertensive Agents / therapeutic use
Autonomic Nervous System / physiopathology*
Blood Pressure / physiology
Creatinine / blood
Diabetes Mellitus, Type 2 / blood,  physiopathology*
Female
Glucose / metabolism
Glucose Metabolism Disorders / blood,  physiopathology
Glucose Tolerance Test
Heart Rate / physiology
Homocysteine / blood*
Humans
Hyperhomocysteinemia / physiopathology*
Insulin / blood
Male
Middle Aged
Sex Factors
Waist-Hip Ratio
Chemical
Reg. No./Substance:
0/Antihypertensive Agents; 11061-68-0/Insulin; 454-28-4/Homocysteine; 50-99-7/Glucose; 60-27-5/Creatinine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Serum gamma-glutamyltransferase and risk of type 2 diabetes mellitus in men and women from the gener...
Next Document:  Effects of 17beta-oestradiol plus different doses of drospirenone on adipose tissue, adiponectin and...